1.The effect of pingyangmycin in the treatment of hemangioma in maxillofacial region: A report of 520 cases
Weidong SHOU ; Binfei YE ; Baiquan SHOU ; Mingyue XU ; Zhaoye MENG
Journal of Practical Stomatology 1995;0(04):-
Objective: To evaluaate the effect of pingyangmycin(PYM ) in the treatment of cavernous hemangioma, strawberry hemangioma and mixed hemangioma in the oro-maxillo-facial region. Methods:The medical records of 520 patients with hemangioma in oro-maxillo-facial region between January 1994 and January 2000 were reviewed. Pingyangmycin(
2.Risk factors affecting the prognosis of adult cardiogenic shock patients treated with extracnrporeal membrane oxygenation
Liusheng HOU ; Gang XIE ; Chonghui JIANG ; Yong YUAN ; Binfei LI ; Weihua ZHENG ; Ye NING ; Shuangbiao ZHAO
Chinese Journal of Emergency Medicine 2012;21(5):510-513
Objective To find out risk factors affecting the prognosis of adult cardiogenic shock patients treated with extracorporeal membrane oxygenation.Methods From January 2003 to December 2010,patients with cardiogenic shock required veno-arterial ECMO after failure of conventional therapy and intra-aortic balloon pump counterpulsation therapy were retrospectively studied. Patients with severe traumatic brain injury,advanced malignancies and multiple organ failure were excluded.All patients were divided into survival group and death group.The risk factors were found out using one-way ANOVA and a multivariate logistic regression analysis was used to determine independent factors associated with survival.Results Thirty-one patients successfully weaned from ECMO. Twenty-two patients were successfully discharged.The average duration of ECMO was 41.56 ± 43.07 hours.Factors associated with failure of hospital discharge were age,pre-ECMO levels of ejection fraction,pre-ECMO levels of lactate,disseminated intravascular coagulation,renal failure and multiorgan failure (P < 0.05). Conclusions Irreversible heart failure and the complications are significantly correlated with survival,and the early use of ECMO for cardiogenic shock and recognize the factors are key to the success of ECMO treatment.
3.Ultrasound monitoring the renal blood flow during extracorporeal membrane oxygenation
Xiaozhen LIU ; Jianwei LI ; Shaozhong LIU ; Binfei LI ; Muqi YE ; Guangxin ZHOU ; Zhiwen ZHENG ; Yonghang HUANG ; Dinghna WEN ; Kun YANG
Journal of Chinese Physician 2017;19(6):824-826,832
Objective To investigate the utilization of ultrasound monitoring the renal blood flow during extracorporeal membrane oxygenation (ECMO).Methods Twentry one cases,who received veinartery ECMO for heart failure,were examinated by bed-side ultrasound before the ECMO initiated,right after the ECMO initiated,each day after the ECMO initiated,and right after the ECMO weaned.The renal interlobar artery peak velocity (Vmax) was measured,and the renal interlobar artery resistant index (RI) was calculated,as well as the values of the serum creatinine (SCr) and blood urea nitrogen (BUN) were recorded.All the data were compared.Results Compared to the variables right after the ECMO initiated,thc Vmax incrcascd (P < 0.05) two days after ECMO initiated and right after the ECMO weaned,while RI (P < 0.05),SCr (P < 0.05) and BUN (P < 0.05) decreased,there being significant differences (P < 0.05).Conclusions While treating patients with extracorporeal membrane oxygenation,the ultrasound can monitoring the renal blood flow effectively,and provide important parameters for the clinical doctors as the basis of the diagnosis and treatment.
4.The clinical application of extracorporeal membrane oxygenation in the perioperative period of general thoracic surgery
Weizhao HUANG ; Hongyu YE ; Yingmeng WU ; Zhou CHENG ; Xiaozu LIAO ; Yi LIANG ; Binfei LI ; Haiming JIANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2019;35(11):693-695